A higher initial dose of methotrexate is not always associated with better clinical outcomes for newly diagnosed rheumatoid arthritis patients, a study shows.
Anti-inflammatory treatment in rheumatoid arthritis patients, especially with infliximab added to methotrexate, improves HDL function and may potentially reduce cardiovascular risk, a study shows.
RA patients with low disease activity in the first trimester of pregnancy, are likely to have low disease activity or reach remission by the third trimester.
Rheumatologists are likely to encounter a wide variety of immune-related adverse events as use of immune checkpoint inhibitors expands.
Researchers have made an important discovery that may lead to new treatment for patients with bullous pemphigoid, a chronic autoimmune skin disease causing blisters.
The elderly can build lower limb bone strength with habitual weight-bearing exercises, not medium or low impact exercise, research shows.
Patients fail to report adverse drug reactions due to poor awareness, but when they do speak up, it’s to prevent others from suffering.
The expanded National Bone Health Alliance definition of osteoporosis may better identify those at elevated fracture risk.
Adalimumab improves function and quality of life for patients with uveitis, shows a study presented at 2015 ACR/ARHP.
IL-6 inhibitors sarilumab, an investigational drug, and tocilizumab, an established treatment in RA, are equally safe, shows two studies presented at ACR/ARHP 2015.